Rana McKay
University of California, San Diego · Alliance for Clinical Trials in Oncology · UCSD
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rana McKay as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:47 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07219576 · Retifanlimab and Ruxolitinib In Solid MalignanciesUniversity of California, San Diego · recruiting · Non Small Cell Lung Carcinoma, Renal Cell Carcinoma · principal investigator
- Ph2NCT06632977 · Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialAlliance for Clinical Trials in Oncology · recruiting · Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 · study chair
- N/ANCT05470036 · Improving Germline Testing in At-Risk Patients With Prostate CancerUniversity of California, San Diego · completed · Prostate Cancer · principal investigator
- Ph1NCT05156905 · Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate CancerUniversity of California, San Diego · terminated · Metastatic Castration-resistant Prostate Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical Protocol and Data ManagementP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2026 · $403,811 awarded in 2026Same name and institution; not confirmed by an ID
- Comprehensive Liquid Biomarkers to Personalize Therapy in Renal Cell CarcinomaR01CA292799 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2025 · $2,984,495 awarded in 2025Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:47 UTC. The ranking covers the 200 most relevant of 64 PubMed records, and a shared surname and initials can bring in a namesake. All 64 on PubMed
- Efficacy and safety of sirolimus in lymphangioleiomyomatosis.N Engl J Med · 2011865 citationsRCR 22.6
- 318 citationsRCR 7.6
- Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.J Clin Oncol · 2023200 citationsRCR 16.8
- 172 citationsRCR 7.1
- Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease.Aliment Pharmacol Ther · 2015128 citationsRCR 5.2
- 125 citationsRCR 4.7
- Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study.J Clin Oncol · 2021124 citationsRCR 5.9
- Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone.J Clin Oncol · 2019121 citationsRCR 4.1
- The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications.J Am Coll Cardiol · 1991120 citationsRCR 4.2
- Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases.J Am Coll Cardiol · 1993101 citationsRCR 4.4